INVESTIGACIÓN EN URGENCIAS
![Foto de INVESTIGACIÓN EN URGENCIAS](/img/grupo.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (7)
2022
-
Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)
Scientific Reports
-
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
eClinicalMedicine, Vol. 51
-
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
eClinicalMedicine, Vol. 50
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130
-
Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19
Journal of General Internal Medicine, Vol. 36, Núm. 12, pp. 3737-3742